FDA Approves First Oral Hormone Therapy for Treating Advanced Prostate Cancer
WASHINGTON, D.C. — The U.S. Food and Drug Administration has approved Orgovyx (relugolix) for the treatment of adult patients with advanced prostate cancer.
Read MoreEnones